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Deletion of autoreactive B cells
Several powerful mechanisms exist to prevent self-reactive B cells from
maturing to secrete potentially destructive autoantibodies. These
mechanisms act in addition to the removal of self-reactive helper T cells.
Large numbers of B cells are produced in the bone
marrow throughout life, but very few become mature
B cells. Most B-cell death is the result of a normal devel-
opmental process which removes the excess of immature
B cells that enter secondary lymphoid organs, such as the
spleen and lymph nodes. Within the pool of immature
B cells, there will be some that bear self-reactive antigen
receptors, which can bind to molecules found in healthy
body tissues. There is now considerable evidence to show
that various specific mechanisms actively remove auto-
reactive B cells from the repertoire, before they have a
chance to mature into cells that secrete autoantibodies.
During the production of B cells from haemopoietic stem
cells, DNA rearrangements combine variable- and con-
stant-region gene segments to create the genes that
encode the immunoglobulin heavy and light chains. The
total repertoire of heavy and light chains that can be gen-
erated by this process is very large, but each B cell carries
only one functional immunoglobulin light chain and one
functional heavy chain gene rearrangement. Consequen-
tly, the 105 or so immunoglobulin molecules expressed by
a B cell on its surface, which are the cell's antigen-specific
receptors, have only one specificity. Activation of a B cell
through its surface receptors can start a series of reactions
that leads to proliferation, followed by differentiation of
the cell's progeny into antibody-secreting cells (plasma
cells) or memory B cells. The antigen-binding portion of
the secreted antibody is encoded by the same rearranged
variable-region gene segments as the surface receptors,
and so has the same specificity.
Some immunoglobulin gene rearrangements produce
B cells with receptors that bind to foreign molecules such
as those associated with pathogenic bacteria or viruses.
When stimulated, B cells of this type produce antibodies
that can prevent or limit infection. But gene rearrange-
ment can also lead to the production of immunoglobulin
that binds to 'self' molecules found within the healthy
body. Activation of self-reactive antigen receptors results
in the production of autoantibodies that might cause
disease. In Graves disease, for example, over-activity of
the thyroid results from the action of an autoantibody
that mimics the action of thyroid-stimulating hormone
by recognizing and binding to the hormone receptor in
the thyroid, leading to over-production of the thyroid
hormone, thyroxin. Some forms of haemolytic anaemia
are also caused by autoimmune reactions in which red
blood cells are destroyed following the binding of auto-
antibodies to one of their surface molecules.
Most of us, however, avoid producing autoantibodies.
This results mainly from mechanisms that cause the death
of autoreactive T and B cells soon after they first express
antigen-specific receptors and before they can be trig-
gered to become effector cells (in the case of T cells) or
antibody-secreting cells. The processes that select and
weed out self-reactive T cells during their development in
the thymus have been the subject of intense investigation.
Less work has been directed at the study of the elimina-
tion or inactivation of autoreactive B cells. It is often
assumed that tolerance to autoantigens is due entirely to
the removal of autoreactive T cells, including those that
would provide the help needed to stimulate autoreactive
B cells to produce antibody, but this is not the case. There
is clear evidence that direct selection also occurs in favour
of B cells that are not self-reactive (Table 1).
Pre-B cells become newly produced, virgin B cells when
they first express immunoglobulin on their surface: It has
long been realized that stimulation of the antigen receptor
at this stage can cause cells to die without leaving the mar-
row. This has been demonstrated experimentally by cross-
linking this surface receptor with antibody against the
constant region of surface immunoglobulin (Table 1) [1].
Nemazee and Biirki [2] demonstrated a similar phen-
omenon in mice carrying transgenes encoding the heavy
and light chains of an antibody against a normal self cell-
surface antigen - a class I major histocompatibility com-
plex (MHC) molecule that is expressed on almost all cells
in the body, including those in the bone marrow. The
transgenes in these mice were expressed in most B cells,
and so virtually all B cells carried antigen receptors specific
for the self MHC molecule. All these B cells died without
leaving the marrow, presumably as a result of interaction
with the self antigen carried on bone marrow cells.
Goodnow, Basten and colleagues [3,4] have identified an
additional mechanism that results in inactivation of
autoreactive B cells at a later stage of development. They
used mice that carried three transgenes; two encoded the
heavy and light chains of an antibody against hen egg
lysozyme, and the third encoded lysozyme itself. A vari-
ety of results are obtained with this system, depending on
the way lysozyme is expressed by the mice (see Table 2).
If lysozyme is present on the surface of cells, the newly
produced anti-lysozyme-specific B cells die without leav-
ing the marrow [4]. This is similar to the effect described
above, in which autoreactive B cells are deleted in
Nemazee and Burki's mice [2], and newly produced
B cells die in mice given anti-immunoglobulin.
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When lysozyme is present, not on cell surfaces but as a
soluble protein in moderate concentrations in the body
fluids, lysozyme-specific B cells do survive and leave the
marrow. Large numbers of these cells are found in the
secondary lymphoid organs, but they are not able to
mount an antibody response against lysozyme. This lack
of response was shown to be attributable to B-cell
unresponsiveness (anergy), over and above the effect of
T-cell tolerance (unresponsiveness or cell deletion) to
lysozyme. Goodnow and colleagues have published
several papers on the nature and extent of this B-cell
anergy and its potential for reversal (reviewed in [5]).
They find that a much lower concentration of secreted
lysozyme, calculated to occupy fewer than 5% of
the anti-lysozyme receptors on B cells, has no obvious
effect on the development of lysozyme-specific B cells,
which can be recruited into responses to antigenic doses
of lysozyme.
It is not obvious that the peripheral B-cell pool of
normal, healthy individuals contains substantial numbers
of naturally occurring anergic B cells with specificity for
autoantigens. A series of experiments by Cyster and col-
leagues [6] indicates that, in normal mice, cells equivalent
to the anergic anti-lysozyme cells found in the triple
transgenic mice have a very poor chance of surviving. In
order to provide an environment containing a mixture of
self-reactive and normal cells, they constructed mice with
chimaeric bone marrow derived from various combina-
tions of lysozyme-expressing or anti-lysozyme-expressing
transgenic and normal mice (Table 2).
In chimaeric mice, the newly produced virgin B cells
carrying the transgenically encoded anti-lysozyme
immunoglobulin on their surface, and the B cells with
normally encoded surface immunoglobulin, seemed
equally capable of migrating from the marrow to the
spleen. In the spleen the lysozyme-specific B cells were
confined to the T zones, areas rich in T cells and anti-
gen-presenting cells. In the chimaeras in which lysozyme
was constitutively expressed in soluble form, the anti-
lysozyme B cells seemed to die in this zone without
entering the area of the lymphoid follicles. The follicular
B cells were recruited from 'normal' cells not carrying
the transgene.
This outcome is different from that in the lysozyme/anti-
lysozyme transgenic mice, in which all B cells carried the
anti-lysozyme surface receptor. In that situation, the aner-
gic B cells did colonize the follicles, but did not progress
to colonize a third peripheral B-cell compartment - the
marginal zone [7]. It seems that, in the presence of large
numbers of non-autoreactive B cells, anergic self-reactive
B cells have little chance of surviving beyond the initial
stages in the secondary lymphoid organs.
How do these results tie in with what we know about
B-cell development and progression through lymphoid
tissues? A normal B cell can pass through three matura-
tion stages without undergoing antigen-driven prolifera-
tion. This progression is .from newly produced virgin B
cell to recirculating follicular B cell, and finally to non-
recirculating marginal zone B cell (Fig. 1) [8]. Newly
produced virgin B cells are found in the marrow, but
they also migrate through the blood to the T zones of
secondary lymphoid organs [9]. The T zones are sites
where a virgin B cell that has bound antigen can make an
antigen-specific interaction with a T cell, resulting in
antibody production. B cells that have taken up antigen
internalize it, break it down to peptides and then present
the resulting peptides on their surface in association with
class II MHC molecules. On entering the T zone, a B
cell that has processed antigen seeks out particular T cells
that cluster in this zone after they too have been activated
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Most newly produced virgin B cells die in secondary
lymphoid tissue about three days after they first express
surface immunoglobulin in the bone marrow [9]. A few
survive, either by being recruited into an antibody
response or by maturing to become recirculating B cells
[8]. Recirculating cells migrate between the secondary
lymphoid organs, which they enter from the blood. In
the lymphoid tissues they pass through the T zones to the
follicles and then return to the blood, usually via the
lymphatic system [11]. If all the newly produced virgin B
cells produced from haemopoietic cells in the marrow
were recruited into the recirculating pool of B cells, this
pool would be renewed about every four days [8]. In
practice, the average life span of recirculating B cells in
normal adult rodents is of the order of a month or two
(reviewed in [12]).
by interaction with antigen held on the specialized den-
dritic antigen-presenting cells found in T zones [10]. If
the B cell finds an activated cognate T cell, it then starts
to proliferate and differentiate. A B cell that has bound an
autoantigen is very unlikely to find a specific helper T
cell, for autoreactive T cells are normally eliminated by
a rigorous selection process [10].
The brief life-span of most virgin B cells is due to the
newly produced cells being deleted because of excess
production, and not because a high proportion of the
cells are autoreactive. This is illustrated by the dramatic
increase in recruitment of newly produced cells to the
recirculating pool that occurs when recirculating cells are
selectively depleted [13]. The increase in recruitment can
rise to a level where a high proportion of the marrow
output of B cells become recirculating cells. These cells
are not anergic, as they are in the lysozyme/anti-
lysozyme transgenic mice, and the marginal zones refill
with a lag of about three days after cells enter the recircu-
lating pool. The rapid rate of replenishment is due to a
decreased rate of death in newly produced virgin B cells,
and not to B-cell proliferation. On the other hand, Gu et
al. [14] found that the antigen-binding repertoire of
peripheral pool B cells of normal mice is more restricted
than the repertoire of bone marrow B cells, indicating
that some process of selection takes place. The difference
was not marked in germ-free mice, suggesting that
environmental antigens might influence selection of the
normal repertoire of antigen receptors carried in the
Fig.1. Photomicrograph of a section of
rat spleen showing the B-cell compart-
ments discussed in the text. The section
is lightly stained with haematoxylin,
which identifies the small lymphocytes
with condensed chromatin in the
T zone (TZ); this area stains light blue.
The main stain on the section is for IgM,
which is present on the surface of most
B-cells; the stain is brown. Newly pro-
duced virgin B cells are found in the
T zone and recirculating B cells pass
through this area to the follicles (F).
Some recirculating B cells mature and
become marginal zone B cells. The
marginal zones (MZ) lie outside the fol-
licles. The remainder of the spleen is
red pulp (RP); IgM-containing plasma
cells are seen in this area. Microscope
magnification x 100.
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recirculating pool of B cells. It is not clear from these
studies whether the effect is due to positive selection of
B cells or to selective deletion.
Nothing is known of the mechanism that assesses the size
of the recirculating B cell pool and recruits sufficient new
B cells to maintain its numbers. One can speculate that
assessment might be carried out by a cell located in the
T zone, a site visited both by recirculating cells and newly
produced virgin B cells. Counting and recruitment could
be achieved if, firstly, the counting-recruiting cell ex-
presses a dominant receptor that is specific for a molecule
present on the surface of all recirculating B cells. Sec-
ondly, engagement of the dominant receptor by recircu-
lating B cells inhibits the expression of a second receptor,
specific for a molecule on newly produced virgin B cells;
loss of recirculating cells would result in the expression of
the second receptor. Thirdly, newly produced virgin B
cells engaging the second receptor receive a signal that
causes them to differentiate into recirculating cells.
The new virgin B cells that have taken up antigen seek
out primed T cells in the T zone. In a scheme of the
type described above, it may be that this diverts them
from attempting to engage the second receptor on the
hypothetical counting-selection cells. In the artificial
transgenic system, where all B cells have taken up anti-
gen, there would be no cells specifically seeking out the
counting-selection cells and some of the newly pro-
duced B cells expressing anti-lysozyme would be ex-
pected to engage the second receptor and so become
recirculating cells.
The experiments in transgenic mice have shown that
autoreactive B cells compete poorly for slots in the recir-
culating B-cell pool, but there is a back-up mechanism
that induces rare persistent autoreactive cells to become
unresponsive to antigen. How do these powerful mecha-
nisms that induce B-cell tolerance to autoantigens fail
in patients who produce pathogenic autoantibodies?
Perhaps the most likely mechanism is the breakdown of
T-cell tolerance, allowing autoreactive newly produced
virgin B cells to receive help from T cells in the T zones.
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